5th Circ. Unwinds Cassava Class Over 'Meme Stock' Claims

By Jessica Corso · October 19, 2026, 6:56 PM EDT

The Fifth Circuit has overturned the class status of investors accusing Cassava Sciences Inc. of making misleading statements about clinical trial results for a potential Alzheimer's drug, saying that a lower...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Bozorgi v. Cassava Sciences

Case Number

25-50855

Court

Appellate - 5th Circuit

Nature of Suit

3160 Stockholders suits

Date Filed

October 21, 2025